Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agents
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agents
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-02-20
DOI
10.1038/s41409-019-0478-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study
- (2018) Guido Ghilardi et al. BONE MARROW TRANSPLANTATION
- Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma
- (2017) Li-Wen Huang et al. HEMATOLOGICAL ONCOLOGY
- Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
- (2017) Michel Attal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival of elderly patients with multiple myeloma—Effect of upfront autologous stem cell transplantation
- (2016) Maximilian Merz et al. EUROPEAN JOURNAL OF CANCER
- Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study
- (2016) Laurent Garderet et al. HAEMATOLOGICA
- Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy
- (2016) Jasmin Stettler et al. LEUKEMIA & LYMPHOMA
- Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
- (2016) Meletios A. Dimopoulos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
- (2016) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study
- (2016) Laurent Garderet et al. HAEMATOLOGICA
- Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
- (2015) A. Palumbo et al. BLOOD
- Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)
- (2015) Yoshiko Atsuta INTERNATIONAL JOURNAL OF HEMATOLOGY
- Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial
- (2015) Francesca Gay et al. LANCET ONCOLOGY
- Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation
- (2014) Shuji Ozaki et al. ACTA HAEMATOLOGICA
- Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation
- (2014) Manish Sharma et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years
- (2014) H W Auner et al. BONE MARROW TRANSPLANTATION
- Autologous Transplantation and Maintenance Therapy in Multiple Myeloma
- (2014) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
- (2013) M. Merz et al. ANNALS OF ONCOLOGY
- Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma
- (2013) Luciano J. Costa et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Trends in Use of and Survival after Autologous Hematopoietic Cell Transplantation in North America, 1995-2005: Significant Improvement in Survival for Lymphoma and Myeloma during a Period of Increasing Recipient Age
- (2013) Philip L. McCarthy et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
- (2012) Y Kanda BONE MARROW TRANSPLANTATION
- Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
- (2011) A. Palumbo et al. BLOOD
- How I treat elderly patients with myeloma
- (2010) J. Mehta et al. BLOOD
- International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
- (2009) A Palumbo et al. LEUKEMIA
- Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis
- (2008) Shaji K. Kumar et al. AMERICAN JOURNAL OF HEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now